171 related articles for article (PubMed ID: 38165941)
1. A TLR4/TRAF6-dependent signaling pathway mediates NCoR coactivator complex formation for inflammatory gene activation.
Abe Y; Kofman ER; Ouyang Z; Cruz-Becerra G; Spann NJ; Seidman JS; Troutman TD; Stender JD; Taylor H; Fan W; Link VM; Shen Z; Sakai J; Downes M; Evans RM; Kadonaga JT; Rosenfeld MG; Glass CK
Proc Natl Acad Sci U S A; 2024 Jan; 121(2):e2316104121. PubMed ID: 38165941
[TBL] [Abstract][Full Text] [Related]
2. RANK ligand converts the NCoR/HDAC3 co-repressor to a PGC1β- and RNA-dependent co-activator of osteoclast gene expression.
Abe Y; Kofman ER; Almeida M; Ouyang Z; Ponte F; Mueller JR; Cruz-Becerra G; Sakai M; Prohaska TA; Spann NJ; Resende-Coelho A; Seidman JS; Stender JD; Taylor H; Fan W; Link VM; Cobo I; Schlachetzki JCM; Hamakubo T; Jepsen K; Sakai J; Downes M; Evans RM; Yeo GW; Kadonaga JT; Manolagas SC; Rosenfeld MG; Glass CK
Mol Cell; 2023 Oct; 83(19):3421-3437.e11. PubMed ID: 37751740
[TBL] [Abstract][Full Text] [Related]
3. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.
Ogawa S; Lozach J; Jepsen K; Sawka-Verhelle D; Perissi V; Sasik R; Rose DW; Johnson RS; Rosenfeld MG; Glass CK
Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14461-6. PubMed ID: 15452344
[TBL] [Abstract][Full Text] [Related]
4. MyD88 adapter-like (Mal)/TIRAP interaction with TRAF6 is critical for TLR2- and TLR4-mediated NF-kappaB proinflammatory responses.
Verstak B; Nagpal K; Bottomley SP; Golenbock DT; Hertzog PJ; Mansell A
J Biol Chem; 2009 Sep; 284(36):24192-203. PubMed ID: 19592497
[TBL] [Abstract][Full Text] [Related]
5. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
6. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint.
Huang W; Ghisletti S; Perissi V; Rosenfeld MG; Glass CK
Mol Cell; 2009 Jul; 35(1):48-57. PubMed ID: 19595715
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
9. Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components.
Dobrovolskaia MA; Medvedev AE; Thomas KE; Cuesta N; Toshchakov V; Ren T; Cody MJ; Michalek SM; Rice NR; Vogel SN
J Immunol; 2003 Jan; 170(1):508-19. PubMed ID: 12496438
[TBL] [Abstract][Full Text] [Related]
10. Pellino-1 Positively Regulates Toll-like Receptor (TLR) 2 and TLR4 Signaling and Is Suppressed upon Induction of Endotoxin Tolerance.
Murphy M; Xiong Y; Pattabiraman G; Qiu F; Medvedev AE
J Biol Chem; 2015 Jul; 290(31):19218-32. PubMed ID: 26082489
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation.
Jean-Charles PY; Zhang L; Wu JH; Han SO; Brian L; Freedman NJ; Shenoy SK
J Biol Chem; 2016 Apr; 291(14):7450-64. PubMed ID: 26839314
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte toll-like receptor 4 mediates lipopolysaccharide-induced hepcidin expression.
Lee YS; Kim YH; Jung YS; Kim KS; Kim DK; Na SY; Lee JM; Lee CH; Choi HS
Exp Mol Med; 2017 Dec; 49(12):e408. PubMed ID: 29217822
[TBL] [Abstract][Full Text] [Related]
13. The optimal corepressor function of nuclear receptor corepressor (NCoR) for peroxisome proliferator-activated receptor γ requires G protein pathway suppressor 2.
Guo C; Li Y; Gow CH; Wong M; Zha J; Yan C; Liu H; Wang Y; Burris TP; Zhang J
J Biol Chem; 2015 Feb; 290(6):3666-79. PubMed ID: 25519902
[TBL] [Abstract][Full Text] [Related]
14. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
[TBL] [Abstract][Full Text] [Related]
15. TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-κB.
Wi SM; Moon G; Kim J; Kim ST; Shim JH; Chun E; Lee KY
J Biol Chem; 2014 Dec; 289(51):35205-14. PubMed ID: 25371197
[TBL] [Abstract][Full Text] [Related]
16. Ataxin-3 represses transcription via chromatin binding, interaction with histone deacetylase 3, and histone deacetylation.
Evert BO; Araujo J; Vieira-Saecker AM; de Vos RA; Harendza S; Klockgether T; Wüllner U
J Neurosci; 2006 Nov; 26(44):11474-86. PubMed ID: 17079677
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
Mizukami J; Takaesu G; Akatsuka H; Sakurai H; Ninomiya-Tsuji J; Matsumoto K; Sakurai N
Mol Cell Biol; 2002 Feb; 22(4):992-1000. PubMed ID: 11809792
[TBL] [Abstract][Full Text] [Related]
18. Chemical inhibition of TRAF6-TAK1 axis as therapeutic strategy of endotoxin-induced liver disease.
Kim SH; Baek SI; Jung J; Lee ES; Na Y; Hwang BY; Roh YS; Hong JT; Han SB; Kim Y
Biomed Pharmacother; 2022 Nov; 155():113688. PubMed ID: 36150308
[TBL] [Abstract][Full Text] [Related]
19. The tyrosine kinase Syk differentially regulates Toll-like receptor signaling downstream of the adaptor molecules TRAF6 and TRAF3.
Lin YC; Huang DY; Chu CL; Lin YL; Lin WW
Sci Signal; 2013 Aug; 6(289):ra71. PubMed ID: 23962979
[TBL] [Abstract][Full Text] [Related]
20. Sinomenine down-regulates TLR4/TRAF6 expression and attenuates lipopolysaccharide-induced osteoclastogenesis and osteolysis.
He L; Duan H; Li X; Wang S; Zhang Y; Lei L; Xu J; Liu S; Li X
Eur J Pharmacol; 2016 May; 779():66-79. PubMed ID: 26965104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
